| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/187152006776930918 |
| P698 | PubMed publication ID | 16712454 |
| P2093 | author name string | Ashok Khar | |
| Sarvjeet Singh | |||
| P433 | issue | 3 | |
| P921 | main subject | curcumin | Q312266 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 259-270 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Anti-Cancer Agents in Medicinal Chemistry | Q15759240 |
| P1476 | title | Biological effects of curcumin and its role in cancer chemoprevention and therapy | |
| P478 | volume | 6 |
| Q38546011 | A high-throughput 3-parameter flow cytometry-based cell death assay |
| Q45874909 | A versatile liquid chromatographic technique for pharmacokinetic estimation of curcumin in human plasma |
| Q38551665 | Acetamides: chemotherapeutic agents for inflammation-associated cancers. |
| Q37222677 | Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells |
| Q57646279 | An Evaluation of the Genotoxicity and Subchronic Oral Toxicity of Synthetic Curcumin |
| Q40249421 | Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro |
| Q33450973 | Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. |
| Q36899138 | Antiproliferative and Apoptotic Effect of Curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in Chronic Myeloid Leukaemic Cells |
| Q35207610 | Apoptosis modulation as a promising target for treatment of systemic sclerosis |
| Q34387568 | Beta-mecaptoethanol suppresses inflammation and induces adipogenic differentiation in 3T3-F442A murine preadipocytes |
| Q30496742 | CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones |
| Q27006530 | Cancer prevention with promising natural products: mechanisms of action and molecular targets |
| Q38948728 | Capsaicin: a novel radio-sensitizing agent for prostate cancer |
| Q34608019 | Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis |
| Q36752040 | Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? |
| Q34409206 | Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats |
| Q54942441 | Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for Delivery to Breast Cancer Cell Line. |
| Q38199088 | Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma |
| Q37020942 | Curcumin Ameliorates Ischemia-Induced Limb Injury Through Immunomodulation. |
| Q90088474 | Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats |
| Q95763679 | Curcumin Protects Neuron against Cerebral Ischemia-Induced Inflammation through Improving PPAR-Gamma Function |
| Q54968424 | Curcumin Treatment is Associated with Increased Expression of the N-Methyl-D-Aspartate Receptor (NMDAR) Subunit, NR2A, in a Rat PC12 Cell Line Model of Alzheimer's Disease Treated with the Acetyl Amyloid-β Peptide, Aβ(25-35). |
| Q35667904 | Curcumin and its analogue induce apoptosis in leukemia cells and have additive effects with bortezomib in cellular and xenograft models |
| Q34625258 | Curcumin and obesity: evidence and mechanisms |
| Q36739771 | Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes |
| Q34606426 | Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia |
| Q37463555 | Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species |
| Q36151210 | Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis |
| Q43272684 | Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats |
| Q37482957 | Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1 |
| Q36916903 | Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo |
| Q34141672 | Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2. |
| Q35403645 | Curcumin pretreatment and post-treatment both improve the antioxidative ability of neurons with oxygen-glucose deprivation |
| Q28577564 | Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase |
| Q36473635 | Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis |
| Q37731658 | Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics |
| Q36149522 | Curcumin treatment recovery the decrease of protein phosphatase 2A subunit B induced by focal cerebral ischemia in Sprague-Dawley rats |
| Q34722123 | Curcumin's effect on intestinal inflammation and tumorigenesis in the ApcMin/+ mouse |
| Q37798220 | Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs |
| Q34107822 | Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. |
| Q28397518 | Curcumin: a double hit on malignant mesothelioma |
| Q42558465 | Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin |
| Q64269161 | Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies |
| Q37294055 | Dimeric approaches to anti-cancer chemotherapeutics |
| Q39629852 | Effect of preparation techniques on the properties of curcumin liposomes: Characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line |
| Q39360764 | Effect of the o-methyl catechols apocynin, curcumin and vanillin on the cytotoxicity activity of tamoxifen |
| Q33567539 | Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells |
| Q36896228 | Extracts of Tripterygium wilfordii Hook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled Trials |
| Q38700105 | Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells |
| Q39170839 | Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells |
| Q54386232 | Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma. |
| Q33277064 | High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin |
| Q40097338 | Immune modulation by curcumin: The role of interleukin-10. |
| Q55510493 | Immunomodulatory activity of curcumin-entrapped poly d,l-lactic-co-glycolic acid nanoparticles in mice. |
| Q37786694 | Immunomodulatory and therapeutic activity of curcumin |
| Q41853728 | Inflammation and cancer |
| Q37089549 | Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin |
| Q38833038 | Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity |
| Q48088000 | Mannich Curcuminoids as Potent Anticancer Agents. |
| Q33747395 | Maternal obesity, inflammation, and developmental programming. |
| Q60302360 | Metabolic treatment of syndrome linked with Parkinson's disease and hypothalamus pituitary gonadal hormones by turmeric curcumin in Bisphenol-A induced neuro-testicular dysfunction of wistar rat |
| Q36668047 | Mitochondrial permeability transition pore as a selective target for anti-cancer therapy |
| Q34612062 | Modulation of aflatoxin B1-mediated genotoxicity in primary cultures of human hepatocytes by diindolylmethane, curcumin, and xanthohumols |
| Q43200912 | Modulation of carbohydrate metabolism during N-methyl N-nitrosourea induced neurotoxicity in mice: role of curcumin |
| Q34573181 | Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions |
| Q35828472 | Natural compounds with proteasome inhibitory activity for cancer prevention and treatment |
| Q37964733 | Natural polyphenols in cancer therapy |
| Q34652379 | Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway |
| Q42281725 | Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. |
| Q99400332 | Optimization and kinetic study of ultrasound assisted deep eutectic solvent based extraction: A greener route for extraction of curcuminoids from Curcuma longa |
| Q26799995 | Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells |
| Q37143309 | Plant-derived natural product research aimed at new drug discovery |
| Q38089143 | Plants of Indian origin in drug discovery |
| Q33282319 | Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy |
| Q38364169 | Portrait of inflammatory response to ionizing radiation treatment. |
| Q34891746 | Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q21143797 | Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model |
| Q42361927 | Protection against Cancer with Medicinal Herbs via Activation of Tumor Suppressor |
| Q41971372 | Protein kinase C: an attractive target for cancer therapy. |
| Q36005646 | Radiation, inflammation, and immune responses in cancer |
| Q44638649 | Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. |
| Q82229863 | Reactions of reactive oxygen species (ROS) with curcumin analogues: Structure–activity relationship |
| Q37370439 | Reactivation of RASSF1A in breast cancer cells by curcumin |
| Q36070178 | Reproductive effects of a pegylated curcumin |
| Q36880907 | Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs |
| Q28386738 | Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix |
| Q40516135 | Silencing of ZRF1 impedes survival of estrogen receptor positive MCF-7 cells and potentiates the effect of curcumin. |
| Q34574742 | Targeting breast stem cells with the cancer preventive compounds curcumin and piperine |
| Q35946294 | The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo |
| Q37802176 | The Nrf2 system as a potential target for the development of indirect antioxidants. |
| Q36964732 | The therapeutic role of targeting protein kinase C in solid and hematologic malignancies |
| Q35836872 | The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention |
| Q28073155 | Unraveling the Anticancer Effect of Curcumin and Resveratrol |
Search more.